TLANTA — The Advisory Committee on Immunization Practices is meeting here this week. The committee is composed of experts who guide policy on how vaccines should be used in the United States. The group’s votes have real-world implications on the vaccines that are available to Americans. They also have implications for the companies that make the vaccines ACIP reviews.
On Wednesday, the committee voted to update its recommendations on influenza vaccines to be used in the upcoming 2017-18 season. There were winners and losers.